O
ALXN

Ossiam’s Alexion Pharmaceuticals ALXN Stock Holding History

Ossiam’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,898
Closed -$922K – 479
2020
Q4 		$922K Sell
5,898
-16,457
-74% -$2.11M 0.03% 193
2020
Q3 		$2.56M Sell
22,355
-2,292
-9% -$247K 0.11% 122
2020
Q2 		$2.77M Buy
24,647
+21,350
+648% +$2.27M 0.18% 104
2020
Q1 		$296K Buy
3,297
+2,786
+545% +$273K 0.02% 300
2019
Q4 		$55K Sell
511
-60,876
-99% -$6.51M ﹤0.01% 458
2019
Q3 		$6.01M Buy
61,387
+61,144
+25,162% +$6.89M 0.42% 53
2019
Q2 		$32K Buy
+243
New +$31.3K ﹤0.01% 439
2019
Q1 		– Sell
-886
Closed -$86K – 336
2018
Q4 		$86K Buy
+886
New +$105K 0.01% 240

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ossiam's ALXN Position: Q1 2021 in Review

Ossiam sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 5,898 shares — an estimated $922K sold.

Ossiam first reported a position in ALXN in Q4 2018 and held it in 8 quarters. The position peaked at $6.01M in Q3 2019. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Ossiam reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Ossiam sold 5,898 Alexion Pharmaceuticals shares in Q1 2021, an estimated $922K.
  • Ossiam first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 8 quarters.
  • Ossiam's Alexion Pharmaceuticals position peaked at $6.01M in Q3 2019.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Ossiam's 13F filing for Q1 2021, filed 17 May 2021.